New muscle relaxants;NEUE MUSKELRELAXANZIEN

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 31, Issue 1, 1996, Pages 2-8

  Diefenbach, C ^a   Buzello, W ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; LAUDANOSINE; MIVACURIUM; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; ENDOTRACHEAL INTUBATION; FLUSHING; HUMAN; HYPOTENSION; MUSCLE RELAXATION; REVIEW; SIDE EFFECT;

EID: 0029972754     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995859     Document Type: Review

References (57)

1. Abouleish E, Abboud T, Lechevalier T, Zhu J, Chalian A, Alford JC Rocuronium (Org 9426) for caesarean section. Brit, J. Anaesth. 1994;73:336-341.
2. Belmont MR, Lien CA, Quessy S, Abou-Donia MM, Abalos A, Eppich L, Savarese JJ: The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;82:1139-1145.
3. Bootj LHDJ, Knape HTA: The neuromuscular blocking effect of ORG 9426. Anaesthesia 1991;46:341-343.
4. Booth MG, Marsh B, Bryden FMM, Robertson EN, Baird WLM: A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia. Anaesthesia 1992;47:832-843.
5. Boyd AH, Eastwood NB, Parker CJR, Hunter JM: Pharmacodynamics of the 1R cis-1'R eis isomer aof atracurium (51W89) in health and chronic renal failure. Brit. J. Anaesth. 1995;74:400-404.
6. Brandom BW, Woelfel SK, Cook DR, Weber S, Powers DM, Weakly JN: Comparison of mivacurium and suxamethonium administered by bolus and infusion. Brit. J. Anaesth. 1989;62:488-493.
7. Broek L van den, Proost JH, Wierda JMKH, Nijoo MD, Hennis PJ: Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block. Eur. J. Anaesthesiol 1994;11:481-487.
8. Caldwell JE, Kitts JB, Heier T, Fahey MR, Lynam DP, Miller RD: The dose-response relationship of mivacurium chloride in humans during nitrous oxide-fentanyl or nitrous oxide-enflurane anesthesia. Anesthesiology 1989;70:31-35.
9. Caldwell JE, Heier T, Kitts JB, Lynam DP, Fahey MR, Miller RD: Comparison of the neuromuscular block induced by mivacurium, suxamerthonium or atracurium during nitrous oxide-fentanyl anaesthesia. Brit. J. Anaesth. 1989;63:393-399.
10. Cook DR; Stiller RL, Weakly NJ, Chakravorti S, Brandom BW, Welch RM: In vitro metabolism of mivacurium chloride (BW B1090U). Anesth. Analg. 1989;68:452-456.
11. Cook DR, Freeman JA, Lai AA, Kang Y, Stiller RL, Aggarwal S, Harrelson JC, Welch RM, Samara B: Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Brit. J. Anaesth. 1992;69:580-585.
12. Cook DR, Chakravorti S, Brandom BW, Stiller RL: Effects of neostigmine, edrophonium and succinylcholine on the in vitro metabolism of mivacurium: clinical correlates. Anesthesiology 1992; 77:A948.
13. Cooper R, Mirakhur RK, Clarke RSJ, Boules Z: Comparison of intubating conditions after administration of ORG 9426 (Rocuronium) and suxamethonium. Brit. J. Anaesth. 1992;69:269-273.
14. Cooper RA, Maddineni VR, Mirakhur RK, Wierda JMKH, Brady M, Fitzpatrick KTJ: Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (ORG 9426) during isoflurane anaesthesia in patients with and without renal failure. Brit. J. Anaesth. 1993;71:222-226.
15. Devlin JC, Head-Rapson AG, Parker CJR, Hunter JM: Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis. Brit. J. Anaesth. 1993;71:227-231.
16. Diefenbach C, Mellinghoff H, Lynch J, Buzello W: Mivacurium: Dose-response relationship and administration by repeated injection or infusion. Anesth. Analg. 1992;74:420-423.
17. Diefenbach C, Mellinghoff H, Grond S, Buzello W: Atracurium and vecuronium: repeated bolus injection versus infusion. Anesth. Analg. 1992;74:519-522.
18. Doenicke A, Mayer M, Nebauer AE, Lorenz W, Moss J, Peter K: Mivacurium and histamine levels: oral premedication with H1/H2 Antagonists prevents side effect. Anesthesiology 1993;79:A931.
19. From RP, Pearson KS, Chot WW, Ahou-Donia M, Sokoll MD: Neuromuscular and cardiovascular effects of mivacurium (BWB1090U) during nitrous oxide-fentanyl-thiopentone and nitrous oxide-halothane anaesthesia. Brit. J. Anaesth. 1990;64:193-198.
20. Goldberg ME, Larijant GE, Azad SS, Sosis M, Seltzer JL et al: Comparing of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium-chloride or succinylcholine in surgical outpatients. Anesth. Analg. 1989;69:93-99.
21. Goldhill DR, Whitehead JP, Emmott RS, Griffith AP, Bracey BJ, Flynn PJ: Neuromuscular and clinical effects of mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anaesthesia. Brit. J. Anaesth. 1991;67:289-295.
22. Head-Rapson AG, Devlin JC, Parker CJR, Hunter JM: Pharmcokinetics of the three isomers of mivacurium and pharmacodynamics of the chiral mixture in hepatic cirrhosis. Brit. J. Anaesth. 1994; 73:613-619.
23. Kao YJ, Le N, Barker SJ: Neostigmine prolongs profound neuromuscular blockade induced by mivacurium in surgical patients. Anesthesiology 1993;79:A929.
24. Khalil M, D'Honneur G, Duvaldestin P, Slavov V, De Hys C, Gomeni R: Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology 1994;80:1241-1247.
25. Khuenl-Brady KS, Koller J, Mair P, Pühringer F, Mitterschiffthaler G: Comparison of vecuronium- and atracurium-induced neuromuscular blockade in post-partum and nonpregnant patients. Anesth. Analg. 1991;72:110-113.
26. Khuenl-Brady KS, Pühringer F, Koller J, Mitterschiffthaler G: Evaluation of the time course of action of maintenance doses of rocuronium (ORG9426) under halothane anaesthesia. Acta Anaesrh. Scand. 1993;37:137-139.
27. Lambalk, L. M., Wit APM de, Wierda JMKH, Hennis PJ, Agoston S: Dose-response relationship and time course of action of org 9426. A new muscle relaxant of intermediate duration evaluated under various anaesthetic techniques. Anaesthesia 1991;46:907-911.
28. rSufentanil anesthesia. Anesth. Analg. 1994;78:318-321.
29. Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ: The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/ opioid/barbiturate anesthesia. Anesthesiology 1994;80:1296-1302.
30. Lien CA, Schmith VD, Belmont MR, Kisor D, Savarese JJ. Pharmacokinetics/ dynamics of 51W89 in healthy patients during opioid anesthesia. Anesthesiology 1994;81:A1082.
31. Lien CA, Belmont MR, Abalos A, Eppich L, Quessy S, Abou-Donia MM, Savarese JJ: The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. Anesthesiology 1995;82:1131-1138.
32. Maddineni VR, Mirakhur RK, McCoy EP, Fee JPH, Clarke RSJ: Neuromuscular effects and intubating conditions following mivacurium: a comparison with suxamethonium. Anaesthesia 1993;48: 940-945.
33. Maddinent VR, Mirakhur RK, McCoy EP, Sharps TDE: Neuromuscular and haemodynamic effects of mivacurium in elderly and young adult patients. Brit. J. Anaesth. 1994;73:608-612.
34. Maehr RB, Belmont MR, Wray DL, Savarese JJ, Wastila WB: Autonomic and neuromuscular effects of mivacurium and isomers in cats. Anesthesiology 1991;75:A772.
35. Magorian T, Flannery KB, Miller RD: Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology 1993;79:913-918.
36. Marshall RJ, Muir AW, Sleigh T, Savage DS: An overview of the pharmacology of rocuronium bromide in experimental animals. Eur. J. Anaesthesiol. 1994;11:S9-S15.
37. Mellinghoff H, Diefenbach C Bischoff A, Grond S, Buzello W: Dose-response relationship of rocuronium bromide during intravenous anaesthesia. Eur. J. Anaesthesiol. 1994;11:S20-S24.
38. Meretoja OA, Taivainen T, Wirtavuort K: Pharmacodynamic effects of 51W89, an isomer of atracurium, in children during halothane anaesthesia. Brit. J. Anaesth. 1995;74:6-11.
39. Motsch J, Leuwer M, Zimmermann J, Böttiger BW, Bach A, Martin E: Neuromuskular blockierende Effekte von Rocuronium bei Kindern unter Halothananaesthesie. Anaesthesist 1994;43:S114.
40. Naguib M, Al-Ghamdt M, Al-Ghamdt A, Hamo I, Nouheid R: Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block. Brit. J. Anaesth. 1993;71:709-714.
41. Østergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby-Mogensen J: Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase. Acta Anaesthesiol. Scand. 1993;37: 314-318.
42. Østergaard D, Jensen FS, Viby-Mogensen J: Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase. Anesthesiology 1995;82:1295-1298.
43. Peschaud JL, Kienlen J, Rey G, Marres F, Momas I, d'Athis F, du Cailar J: Pharmacodynamics of vecuronium in patients with and without renal failure. Anesthesiology 1990;73:A916.
44. Petersen RS, Bailey PL, Kalameghan R, Ashwood ER: Prolonged neuromuscular block after Mivacurium. Anesth. Analg. 1993;76: 194-196.
45. Pühringer F, Khuenl-Brady KS, Koller J, Mitterschiffthaler G: Evaluation of the endotracheal intubating conditions of rocuronium (ORG9426) and succinylcholine in outpatient surgery. Anesth. Analg. 1992;75:37-40.
46. Quill TJ, Begin M, Glass PSA, Ginsberg B, Gorback MS: Clinical responses to Org9426 during isoflurane anesthesia. Anesth. Analg. 1991;72:203-206.
47. Rupp SM, Castagnoli KP, Fisher DM, Miller RD: Paricuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly adults. Anesthesiology 1987;67:45-49.
48. Scott RPF, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG: Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response. Bnt. J. Anaesth. 1985;57:550-553.
49. Shanks CA, Fragen RJ, Ling D: Continuous intravenous infusion of rocuronium (org9426) in patients receiving balanced, enflurane, or isoflurane anesthesia. Anesthesiology 1993;78:649-651.
50. Sarner JB, Brandom BW, Woelfel SK, Dong ML, Horn MC, Cook DR, McNulty BF, Foster VJ: Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia. Anesth. Analg. 1989;68:116-121.
51. Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RPF, Sunder N, Weakly JN, Wastila WB, El-Sayad HA: The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). Anesthesiology 1988;68:723-732.
52. Savarese JJ, Ali HH, Basta SJ, Scott RPF, Embree PB, Wastila WB, Abou-Donia MM, Gelb C: The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxideopiate-barbiturate anesthesia. Anesthesiology 1989;70:386-394.
53. Tullock W, Scott V, Smith DA, Phillips L, Cook DR: Kinetics/ Dynamics of 51W89 in liver transplant patients and healthy patients. Anesthesiology 1994;81:A1076.
54. Vuksanaj D, Skjonsby B, Dunbar B: Pharmacokinetics and pharmacodynamics of intubating dose of ORG9426 (Rocuronium) in children. Anesthesiology 1993;79:A1127.
55. Ward S, Boheimer N, Weatberley BC, Simmonds RJ, Dopson TA: Pharmacokinetics of atracurium and its metabolites in patients with normal renal function and in patients in renal failure. Brit. J. Anaesth. 1987;59:697-706.
56. Weber S, Brandom BW, Powers DM et al: Mivacurium chloride (BWB1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients. Anesth. Analg. 1988;67:495-499.
57. Wrigley SR, Jones RM, Harrop-Griffith AW, Platt MW: Mivacurium chloride: a study to evaluate its use during propofol-nitrous oxide anaesthesia. Anaesthesia 1992;47:653-657.